<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">81224</article-id><article-id pub-id-type="doi">10.7554/eLife.81224</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Computational and Systems Biology</subject></subj-group></article-categories><title-group><article-title>Pan-cancer association of DNA repair deficiencies with whole-genome mutational patterns</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-285445"><name><surname>Sørensen</surname><given-names>Simon Grund</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-146975"><name><surname>Shrikhande</surname><given-names>Amruta</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-285447"><name><surname>Poulsgaard</surname><given-names>Gustav Alexander</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-285448"><name><surname>Christensen</surname><given-names>Mikkel Hovden</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-285449"><name><surname>Bertl</surname><given-names>Johanna</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-304397"><name><surname>Laursen</surname><given-names>Britt Elmedal</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-146976"><name><surname>Hoffmann</surname><given-names>Eva R</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-69524"><name><surname>Pedersen</surname><given-names>Jakob Skou</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7236-4001</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Molecular Medicine</institution>, <institution>Aarhus University Hospital</institution>, <addr-line><named-content content-type="city">Aarhus</named-content></addr-line>, <country>Denmark</country></aff><aff id="aff2"><institution content-type="dept">Department of Cellular and Molecular Medicine</institution>, <institution>University of Copenhagen</institution>, <addr-line><named-content content-type="city">Copenhagen</named-content></addr-line>, <country>Denmark</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-154794"><name><surname>Rathmell</surname><given-names>W Kimryn</given-names></name><role>Reviewing editor</role><aff><institution>Vanderbilt University Medical Center</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>eva@sund.ku.dk</email> (EH);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>jakob.skou@clin.au.dk</email> (JP);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>08</day><month>03</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e81224</elocation-id><history><date date-type="received"><day>20</day><month>06</month><year>2022</year></date><date date-type="accepted"><day>26</day><month>02</month><year>2023</year></date></history><permissions><copyright-statement>© 2023, Sørensen et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Sørensen et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-81224-v1.pdf"/><abstract><p>DNA repair deficiencies in cancers may result in characteristic mutational patterns, as exemplified by deficiency of <italic>BRCA1/2</italic> and efficacy prediction for PARP-inhibitors. We trained and evaluated predictive models for loss-of-function (LOF) of 145 individual DDR genes based on genome-wide mutational patterns, including structural variants, indels, and base-substitution signatures. We identified 24 genes whose deficiency could be predicted with good accuracy, including expected mutational patterns for <italic>BRCA1/2</italic>, <italic>MSH3/6</italic>, <italic>TP53</italic>, and <italic>CDK12</italic> LOF variants. <italic>CDK12</italic> is associated with tandem-duplications, and we here demonstrate that this association can accurately predict gene deficiency in prostate cancers (area under the ROC curve=0.97). Our novel associations include mono- or biallelic LOF variants of <italic>ATRX, IDH1, HERC2, CDKN2A, PTEN</italic>, and <italic>SMARCA4</italic>, and our systematic approach yielded a catalogue of predictive models, which may provide targets for further research and development of treatment, and potentially help guide therapy.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100009708</institution-id><institution>Novo Nordisk Fonden</institution></institution-wrap></funding-source><award-id>NNF15OC0016662</award-id><principal-award-recipient><name><surname>Hoffmann</surname><given-names>Eva R</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000289</institution-id><institution>Cancer Research UK</institution></institution-wrap></funding-source><award-id>C23210/A7574</award-id><principal-award-recipient><name><surname>Hoffmann</surname><given-names>Eva R</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004836</institution-id><institution>Danmarks Frie Forskningsfond</institution></institution-wrap></funding-source><award-id>8021-00419B</award-id><principal-award-recipient><name><surname>Pedersen</surname><given-names>Jakob Skou</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100008363</institution-id><institution>Kræftens Bekæmpelse</institution></institution-wrap></funding-source><award-id>R307-A17932</award-id><principal-award-recipient><name><surname>Pedersen</surname><given-names>Jakob Skou</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002739</institution-id><institution>Aarhus Universitets Forskningsfond</institution></institution-wrap></funding-source><award-id>AUFF-E-2020-6-14</award-id><principal-award-recipient><name><surname>Pedersen</surname><given-names>Jakob Skou</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100012526</institution-id><institution>Sundhedsvidenskabelige Fakultet, Aarhus Universitet</institution></institution-wrap></funding-source><award-id>PhD stipend</award-id><principal-award-recipient><name><surname>Sørensen</surname><given-names>Simon Grund</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100009618</institution-id><institution>Sundhed, Region Midtjylland</institution></institution-wrap></funding-source><award-id>A2972</award-id><principal-award-recipient><name><surname>Poulsgaard</surname><given-names>Gustav Alexander</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001732</institution-id><institution>Danmarks Grundforskningsfond</institution></institution-wrap></funding-source><award-id>DNRF115</award-id><principal-award-recipient><name><surname>Hoffmann</surname><given-names>Eva R</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: We analysed data generated and made available by the Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium of the International Cancer Genome Consortium (ICGC) and The Cancer Genome Atlas (TCGA) as well as the Hartwig Medical Foundation (HMF). The research conforms to the principles of the Helsinki Declaration.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>This study is based on analyses of human germline and cancer somatic variant data. The data sets were generated and made available by the Pan-Cancer Analysis of Whole Genomes (PCAWG) consortium and from the Hartwig Medical Foundation (HMF). The majority of the data cannot be publicly accessed as it includes protected personal data, including germline variants, which cannot be made publicly available. However, accession to the underlying data sets can be achieved through applications to ICGC/TCGA and HMF as described below.The public parts of the PCAWG data set are available at https://dcc.icgc.org/releases/PCAWG, whereas controlled files may be accessed through applications to gbGaP and DACO, which should include a project proposal, as instructed on this site https://docs.icgc.org/pcawg/data/. The ICGC study ID of the project is EGAS00001001692.The HMF data used in this project may be found by accession code DR-044 and can be obtained by submitting an application with a project proposal to the Hartwig Medical Foundation (https://www.hartwigmedicalfoundation.nl/en).Non-personal summary data have been supplied in supplementary tables S1 to S9:Supplementary Table 1: All included tumours and their primary tumour locationsSupplementary Table 2: 736 DDR genes, hg19 coordinates and the number ofpathogenic events across 6,065 cancer genomesSupplementary Table 3: All SBS signature contributions, indels counts, and1104 SV counts, per sample; zip-compressed; tab-separated values (.tsv), may be opened in Microsoft ExcelSupplementary Table 4: All SBS signature contributions, indels counts, andSV counts, per sample, log-transformed and scaled to z-scores; zip-compressed; tab-separated values (.tsv), may be opened in Microsoft ExcelSupplementary Table 5: Proposed Etiologies of base substitution signaturesSupplementary Table 6: All models (n=535)Supplementary Table 7: Pathogenic events in each of the 535 LOF-setsSupplementary Table 8: Shortlisted models (n=48)Supplementary Table 9: Correlation between features in shortlisted modelsSupplementary Table 10: Survival analysis for the shortlisted modelsThe third-party software used for data analysis includes:Pathogenicity annotation using CADD annotation software, which may be accessed at https://cadd.gs.washington.eduSignature analysis using Signature Tools Lib, which has been installed from the GitHub: https://github.com/Nik-Zainal-Group/signature.tools.libCode that we developed locally for the analysis can be accessed at:https://github.com/SimonGrund/DDR_Predict</p></sec><supplementary-material><ext-link xlink:href="elife-81224-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>